# Seed Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/seed-health

- Industry: Biotechnology
- Headquarters: Venice, US
- Website: www.seedhealth.com
- Total disclosed funding: $41M
- Latest round: Series A (May 1, 2021)
- Investors on record: 15

## About

Based in the US, Seed Health, Inc. operates as a forward-thinking biotechnology firm focused on innovative microbiome-centric health solutions that enhance overall human health and wellness through advanced scientific methodologies.Seed Health, Inc. was founded in 2016 in Venice, US. The company specializes in microbiome health solutions and has pivoted its operational focus towards utilizing computational biology and microbial genomics. The founders, Raja Dhir and Stephen Ap, have a history of entrepreneurial ventures, though specific prior companies are not outlined. The company raised USD 40.62 mn in Series A funding in May 2021 from investors including 8VC, ARTIS Ventures, Founders Fund, Gisev Family Office, and The Craftory Limited, which represents the total amount raised to date.Seed Health focuses on developing a range of microbiome-centric solutions that leverage advanced computational biology and microbial genomics to optimize human health. Their core offerings include prebiotics, probiotics, postbiotics, and synbiotics that target various health applications, such as gastrointestinal, dermatological, and metabolic health. These products aim to establish and maintain a healthy symbiotic relationship between the host and its microbiome, especially during critical developmental windows such as infancy and aging. By employing multi-omics and controlled data sets, Seed Health seeks to innovate and validate these products, ensuring efficacy for end-users, which include consumers and healthcare practitioners. The company distributes its products across various global markets, focusing primarily on North America and Europe, where there is increasing awareness of microbiome health and its implications for overall well-being.Seed Health generates revenue through a multi-faceted business model that includes direct-to-consumer sales as well as partnerships with healthcare practitioners and retailers. Their flagship products, which include a range of specialized formulations for different life stages and health conditions, are offered through subscription models and retail channels, enhancing accessibility for consumers. Transactions may involve individual product purchases or subscription plans that provide ongoing access to their microbiome solutions. The structured pricing plans reflect the premium nature of their innovative health products, which are typically backed by robust clinical research and development efforts. This approach not only fosters customer loyalty but also supports a scalable model for expanding their reach within the health and wellness market.Seed Health plans to utilize recent funding from their Series A round, raised on May 1, 2021, to support the development of new products aimed at expanding their microbiome solutions product line. The company is targeting specific markets in Europe and Asia for expansion, with plans to enter these regions by 2023. Upcoming product releases are anticipated to focus on addressing emerging health trends related to microbiome science, although specific launch dates have yet to be announced.

## Funding rounds

- Series A, May 1, 2021 — e squared
- Series A, Apr 7, 2021, $41M — Founders Fund, ARTIS Ventures, 8VC, The Craftory Limited, Gisev Family Office
- Seed, Mar 11, 2019 — Greycroft, Alumni Ventures Group
- Seed, Jun 1, 2017 — Founders Fund, Greycroft, Slow, V1.VC, K2 Global, M13, Wisdom VC, JAWS, MaC Venture Capital

## Investors

- Founders Fund (https://capitalatlas.ai/funds/founders-fund) — Seed, Series A
- Greycroft (https://capitalatlas.ai/funds/greycroft) — Seed
- Slow (https://capitalatlas.ai/funds/slow) — Seed
- V1.VC (https://capitalatlas.ai/funds/v1-vc) — Seed
- K2 Global (https://capitalatlas.ai/funds/k2-global) — Seed
- M13 (https://capitalatlas.ai/funds/m13) — Seed
- Wisdom VC (https://capitalatlas.ai/funds/wisdom-vc) — Seed
- JAWS — Seed
- MaC Venture Capital (https://capitalatlas.ai/funds/mac-venture-capital) — Seed
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Seed
- ARTIS Ventures (https://capitalatlas.ai/funds/artis-ventures) — Series A
- 8VC (https://capitalatlas.ai/funds/8vc) — Series A
- The Craftory Limited — Series A
- Gisev Family Office — Series A
- e squared (https://capitalatlas.ai/funds/e-squared) — Series A